scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1049002148 |
P356 | DOI | 10.1007/S10545-010-9228-X |
P698 | PubMed publication ID | 20978940 |
P2093 | author name string | Irene Paradisi | |
Sergio Arias | |||
P2860 | cites work | Structure of human porphobilinogen deaminase at 2.8 A: the molecular basis of acute intermittent porphyria | Q27653713 |
May 2006 update in porphobilinogen deaminase gene polymorphisms and mutations causing acute intermittent porphyria: comparison with the situation in Slavic population | Q28288056 | ||
The CpG dinucleotide and human genetic disease | Q28296311 | ||
Quantitative analysis of SMN1 gene and estimation of SMN1 deletion carrier frequency in Korean population based on real-time PCR | Q33629502 | ||
Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity | Q33708953 | ||
Recommendations for the diagnosis and treatment of the acute porphyrias | Q33985744 | ||
Finishing touches: post-translational modification of protein factors involved in mammalian pre-mRNA 3' end formation | Q34777700 | ||
Acute porphyrias in the Argentinean population: a review. | Q35191975 | ||
Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria | Q35250368 | ||
A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes I: general principles and overview | Q36463097 | ||
Porphyria in Sweden | Q36734856 | ||
Acute intermittent porphyria caused by an arginine to histidine substitution (R26H) in the cofactor-binding cleft of porphobilinogen deaminase | Q38317060 | ||
A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies | Q40507676 | ||
Haplotype analysis of Norwegian and Swedish patients with acute intermittent porphyria (AIP): Extreme haplotype heterogeneity for the mutation R116W. | Q41920086 | ||
A simple and nonradioactive method for detecting the Rb1.20 DNA polymorphism in the retinoblastoma gene | Q43146253 | ||
Liver transplantation for acute intermittent porphyria: a viable treatment? | Q43172810 | ||
Evidence for an ancestral founder of the common R116W mutation in the hydroxymethylbilane synthase gene in acute intermittent porphyria in The Netherlands. | Q43298235 | ||
Porphobilinogen deaminase gene in African and Afro-Caribbean ethnic groups: mutations causing acute intermittent porphyria and specific intragenic polymorphisms | Q43934792 | ||
Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene | Q44173479 | ||
Ancestral founder of mutation W283X in the porphobilinogen deaminase gene among acute intermittent porphyria patients. | Q44302301 | ||
Molecular analysis of acute intermittent porphyria: mutation screening in 20 patients in Germany reveals 11 novel mutations | Q44788415 | ||
An analysis of 112 acute porphyric attacks in Cape Town, South Africa: Evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity | Q45219213 | ||
Huntington disease mutation in Venezuela: age of onset, haplotype analyses and geographic aggregation | Q45307339 | ||
Acute intermittent porphyria--impact of mutations found in the hydroxymethylbilane synthase gene on biochemical and enzymatic protein properties | Q45775369 | ||
Porphyria in Switzerland, 15 years experience | Q45836537 | ||
Hereditary hepatic porphyrias in Finland | Q46244153 | ||
Detection of a R173W mutation in the porphobilinogen deaminase gene in the Nova Scotian "foreign Protestant" population with acute intermittent porphyria: a founder effect | Q46376502 | ||
HMBS mutations in Chinese patients with acute intermittent porphyria. | Q51444444 | ||
The hepatic porphyrias: experience with 105 cases | Q67875866 | ||
Detection of four mutations in six unrelated South African patients with acute intermittent porphyria | Q71201178 | ||
Phenotypic and population features of MPS IH in Quibor, Venezuela | Q71643967 | ||
A modified spectrophotometric assay for porphobilinogen deaminase: its application in the detection of both carriers and patients with acute intermittent porphyria | Q71925329 | ||
Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene | Q72253560 | ||
The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine | Q73933517 | ||
Comparison of complementary and genomic DNA sequencing for the detection of mutations in the HMBS gene in British patients with acute intermittent porphyria: identification of 25 novel mutations | Q78147289 | ||
Novel HMBS founder mutation and significant intronic polymorphism in Spanish patients with acute intermittent porphyria | Q80831939 | ||
Porphyrias | Q81277608 | ||
Porphyrias | Q83185413 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | acute intermittent porphyria | Q424247 |
single-nucleotide polymorphism | Q501128 | ||
P304 | page(s) | S455-63 | |
P577 | publication date | 2010-10-27 | |
P1433 | published in | Journal of Inherited Metabolic Disease | Q6295359 |
P1476 | title | Marked geographic aggregation of acute intermittent porphyria families carrying mutation Q180X in Venezuelan populations, with description of further mutations | |
P478 | volume | 33 Suppl 3 |
Q35039960 | Acute intermittent porphyria associated with respiratory failure: a multidisciplinary approach |
Q47923220 | GBA mutations in Gaucher type I Venezuelan patients: ethnic origins and frequencies |
Q34457673 | Seven Novel Mutations in Bulgarian Patients with Acute Hepatic Porphyrias (AHP). |
Q41148958 | Spinocerebellar ataxias in Venezuela: genetic epidemiology and their most likely ethnic descent |
Search more.